Investing News NetworkMarch 17, 2025Cleo Diagnostics (COV:AU) has announced CLEO Delivers Commercial Development MilestoneDownload the PDF here.
Investing News Network27 February Appendix 4D and Half Yearly Accounts Cleo Diagnostics (COV:AU) has announced Appendix 4D and Half Yearly AccountsDownload the PDF here.
Investing News Network31 January Quarterly activities and cashflow report Cleo Diagnostics (COV:AU) has announced Quarterly activities and cashflow reportDownload the PDF here.
Investing News Network09 December 2024 CLEO Further Expands Ovarian Cancer Trial with Siles Health Cleo Diagnostics (COV:AU) has announced CLEO Further Expands Ovarian Cancer Trial with Siles HealthDownload the PDF here.
Investing News Network26 November 2024 The Royal Women's Hospital Joins CLEO Ovarian Cancer Trial Cleo Diagnostics (COV:AU) has announced The Royal Women's Hospital Joins CLEO Ovarian Cancer TrialDownload the PDF here.
Investing News Network29 August FY25 Preliminary Results Summary and Company Update Cardiex Limited (CDX:AU) has announced FY25 Preliminary Results Summary and Company UpdateDownload the PDF here.
Investing News Network29 August Appendix 4E Cardiex Limited (CDX:AU) has announced Appendix 4EDownload the PDF here.
Investing News Network29 August Appendix 4E and Preliminary Final Report Radiopharm Theranostics (RAD:AU) has announced Appendix 4E and Preliminary Final ReportDownload the PDF here.
Investing News Network27 August Appendix 4E and Annual Report Invion Limited (IVX:AU) has announced Appendix 4E and Annual ReportDownload the PDF here.
Investing News Network20 August Orphan Drug Designation Granted by U.S. FDA for Anal Cancer Invion Limited (IVX:AU) has announced Orphan Drug Designation Granted by U.S. FDA For Anal CancerDownload the PDF here.
Investing News Network19 August Trading Halt Invion Limited (IVX:AU) has announced Trading HaltDownload the PDF here.